# Boswellin Super (Boswellia serrata)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/boswellin-super
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Boswellia serrata extract, Salai guggal, Indian frankincense, Shallaki, Boswellic acid extract, Standardized Boswellia extract, 3-O-acetyl-boswellic acid concentrate, AKBA extract, Boswellia serrata gum resin

## Overview

Boswellin Super is a standardized extract of Boswellia serrata resin, concentrated in boswellic acids—particularly AKBA (acetyl-11-keto-β-boswellic acid)—which selectively inhibit 5-lipoxygenase (5-LOX) to reduce leukotriene-driven [inflammation](/ingredients/condition/inflammation). Its primary clinical application is reducing joint pain and improving mobility in osteoarthritis patients.

## Health Benefits

• Reduces osteoarthritis pain and improves joint function - demonstrated in a 12-week RCT with 48 adults showing significant WOMAC score improvements (p<0.05)
• Decreases joint stiffness - clinical evidence from the same osteoarthritis trial showed significant improvements vs placebo
• Inhibits [inflammatory pathway](/ingredients/condition/inflammation)s - in vitro studies show inhibition of leukotriene B4 and C4 in human neutrophils (IC50 8.43-8.48 μg/ml)
• Suppresses multiple inflammatory enzymes - mechanistic studies demonstrate inhibition of 5-LOX, COX-1, and NF-κB activation
• Traditional anti-inflammatory support - over 5,000 years of Ayurvedic use for inflammation and joint pain

## Mechanism of Action

AKBA (acetyl-11-keto-β-boswellic acid), the most potent boswellic acid, non-redox inhibits 5-lipoxygenase (5-LOX), blocking the conversion of arachidonic acid into pro-inflammatory leukotrienes such as LTB4, which are key mediators of joint [inflammation](/ingredients/condition/inflammation). Boswellic acids also suppress NF-κB signaling, reducing downstream expression of COX-2, TNF-α, and IL-1β without the gastrointestinal damage associated with NSAID-mediated COX-1 inhibition. Additionally, Boswellia extracts inhibit human leukocyte elastase (HLE), an enzyme that degrades cartilage proteoglycans, offering a potential chondroprotective effect.

## Clinical Summary

A 12-week randomized, double-blind, placebo-controlled trial (n=48 adults with knee osteoarthritis) demonstrated significant improvements in WOMAC pain, stiffness, and physical function scores (p<0.05) in the Boswellin Super group versus placebo. A separate 90-day crossover RCT published in Phytomedicine (n=30) found Boswellia serrata extract reduced knee pain by approximately 32% and improved walking distance significantly compared to placebo. Systematic reviews and meta-analyses of boswellic acid extracts generally rate evidence quality as moderate, with consistent positive signals for osteoarthritis outcomes but noting small sample sizes and short follow-up periods across most trials. Evidence for conditions beyond osteoarthritis, such as rheumatoid arthritis or sports injuries, remains preliminary and requires larger confirmatory studies.

## Nutritional Profile

Boswellin Super is a standardized extract of Boswellia serrata resin, not a conventional food ingredient, so macronutrient and micronutrient profiles are not the primary characterization framework. Key bioactive compounds include: Boswellic acids (primary actives) standardered to approximately 65-70% total boswellic acids by weight in the 'Super' designation, comprising β-boswellic acid, α-boswellic acid, 11-keto-β-boswellic acid (KBA), and acetyl-11-keto-β-boswellic acid (AKBA) — AKBA is considered the most pharmacologically potent component, typically present at 10-20% of total boswellic acids in standardized extracts. The raw resin contains approximately 5-10% essential oils (monoterpenes and diterpenes including α-thujene, p-cymene), polysaccharides (arabinose, galactose-based), and small quantities of triterpene alcohols. Protein and fiber content are negligible in the concentrated extract form. Macronutrient breakdown is not clinically relevant at typical supplemental doses (typically 100-500 mg extract per serving). Bioavailability note: Boswellic acids, particularly AKBA, have inherently poor oral bioavailability due to low aqueous solubility and extensive first-pass [metabolism](/ingredients/condition/weight-management); lipid-based formulations or piperine co-administration can enhance absorption by up to 2-3 fold. Mineral content is not significantly characterized in the extract form.

## Dosage & Preparation

Clinically studied dosage: 250 mg/day (one capsule) standardized to 30% AKBA, 7.5% β-boswellic acid, 3.5% acetyl-β-boswellic acid, and 1.5% 11-keto-β-boswellic acid, delivering 75 mg total boswellic acids. Forms include oral capsules or tablets with enteric coatings for intestinal release. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Boswellia serrata is generally well tolerated at standard doses of 100–400 mg of standardized extract (30–65% boswellic acids) daily, with the most commonly reported side effects being mild gastrointestinal complaints including nausea, acid reflux, and diarrhea affecting a small percentage of users. Because boswellic acids modulate arachidonic acid [metabolism](/ingredients/condition/weight-management) similarly to NSAIDs, caution is warranted when co-administering with anticoagulants such as warfarin or antiplatelet drugs like aspirin, as additive effects on platelet aggregation are theoretically possible. Boswellia may interact with CYP450-metabolized drugs, particularly CYP2C9 and CYP3A4 substrates, potentially altering their plasma concentrations, though clinical pharmacokinetic data in humans remain limited. Pregnant and breastfeeding women should avoid use due to insufficient safety data, and individuals with known resin or tree-sap allergies should consult a physician before use.

## Scientific Research

A randomized, double-blind, placebo-controlled trial using Boswellin Super (standardized to 30% AKBA) at 250 mg/day for 12 weeks in 48 adults with knee osteoarthritis showed significant improvements in pain, joint function, and stiffness compared to placebo (p<0.05), with no serious adverse events reported (PMC11291344). In vitro studies on human polymorphonuclear leukocytes demonstrated boswellic acids' inhibition of leukotriene synthesis with IC50 values of 8.43-8.48 μg/ml.

## Historical & Cultural Context

Boswellia serrata resin (Salai guggal) has been used for over 5,000 years in Ayurvedic medicine for inflammation, arthritis, joint pain, and respiratory issues. The resin was traditionally applied topically or taken orally for its [anti-inflammatory](/ingredients/condition/inflammation) and analgesic effects in Indian healing systems.

## Synergistic Combinations

Glucosamine, Chondroitin, MSM, Turmeric Extract, Type II Collagen

## Frequently Asked Questions

### How long does Boswellia serrata take to work for joint pain?

Clinical trials indicate meaningful improvements in joint pain and stiffness typically emerge within 4–8 weeks of consistent daily use. The 12-week RCT with Boswellin Super showed statistically significant WOMAC score improvements (p<0.05), suggesting benefits continue to build over the full treatment period rather than occurring immediately.

### What is the recommended dosage of Boswellin Super?

Most clinical trials supporting joint health benefits used standardized Boswellia serrata extracts at 100–400 mg per day, standardized to contain 30–65% total boswellic acids or at least 10% AKBA. Boswellin Super products are typically standardized to a higher AKBA content than generic extracts, so following label dosing—usually 100–200 mg once or twice daily with food—is recommended to match studied formulations.

### Is Boswellia serrata better than ibuprofen for arthritis?

Head-to-head trials are limited, but a 6-week comparative study found Boswellia extract produced similar pain relief to valdecoxib (a COX-2 inhibitor) in knee osteoarthritis, with the key advantage that boswellic acids do not inhibit COX-1 and therefore carry a lower risk of gastrointestinal ulceration. However, Boswellia generally has a slower onset of action than NSAIDs like ibuprofen, making it better suited for long-term management than acute pain relief.

### Can you take Boswellia serrata with turmeric or curcumin?

Combining Boswellia serrata with curcumin is a well-studied and commonly used strategy, as the two compounds target complementary inflammatory pathways—AKBA inhibits 5-LOX and curcumin inhibits COX-2 and NF-κB signaling. A randomized trial comparing a Boswellia-curcumin combination to celecoxib found the combination produced superior pain reduction and functional improvement over 12 weeks, suggesting additive or synergistic anti-inflammatory effects with a favorable safety profile.

### Does Boswellia serrata have any effect on gut health or inflammatory bowel disease?

Boswellic acids' 5-LOX inhibition reduces intestinal leukotriene synthesis, which has been studied in Crohn's disease and ulcerative colitis. A small RCT (n=102) published in the European Journal of Gastroenterology found Boswellia extract (H15) maintained remission in Crohn's disease as effectively as mesalazine over 12 months, though the evidence base remains limited and it is not a standard-of-care recommendation; patients should consult a gastroenterologist before use.

### Is Boswellia serrata safe to take long-term?

Boswellia serrata has demonstrated safety in clinical trials lasting 12 weeks or longer, with minimal adverse effects reported compared to placebo. However, long-term safety beyond 6 months requires additional research, and individuals should consult healthcare providers before extended use, particularly those with existing health conditions or taking medications.

### Who benefits most from Boswellia serrata supplementation?

Boswellia serrata is most beneficial for individuals with osteoarthritis or joint-related inflammation, as clinical evidence shows significant improvements in pain scores and stiffness in this population. It may also benefit those seeking natural anti-inflammatory support, though people with inflammatory bowel disease should consult their doctor first due to potential gastrointestinal effects.

### What makes Boswellin Super different from standard Boswellia serrata extracts?

Boswellin Super is a branded, standardized extract of Boswellia serrata formulated to ensure consistent levels of active boswellic acids, which are the compounds responsible for its anti-inflammatory effects. Standardized extracts provide more reliable dosing and efficacy compared to non-standardized preparations, making clinical outcomes more predictable and reproducible.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*